Datavant
Dan Walsh, chief information security officer of Datavant, sat down with MobiHealthNews in-person to discuss AI and its evolution compared to other tech.
Leaders say AI will reshape jobs without replacing the human core of care.
Next year, AI will move beyond administrative support to become a workflow-integrated tool that drives predictive and proactive care and sees true adoption, according to healthcare leaders.
This year was marked by shocking events alongside soaring company valuations, policy transformation, rapid AI adoption and landmark investments in women’s health.
Industry leaders say 2025 marked AI’s shift from hype to practical impact, though the technology remains unready for full-scale adoption and ongoing concerns about ethics and bias persist.
The acquisition expands Datavant's capabilities to help insurance and legal professionals with AI-enabled tools for automated medical record review and predictive analytics.
The acquisition will help Datavant transition its manual health records request process to digital.
Arnaub Chatterjee, Datavant president and GM of life sciences, says the company will streamline data linking and evidence generation across real-world and clinical trial data.
The combination will allow healthcare and life sciences companies to respond more efficiently to research questions.
Via Datavant's data utility and privacy platform, Boehringer Ingelheim can evaluate data and streamline data discovery.